Cargando…
Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors
Inositol polyphosphates (IPs) are a group of inositol metabolites that act as secondary messengers for external signalling cues. They play various physiological roles such as insulin release, telomere length maintenance, cell metabolism, and aging. Inositol hexakisphosphate kinase 2 (IP6K2) is a key...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075506/ https://www.ncbi.nlm.nih.gov/pubmed/37013838 http://dx.doi.org/10.1080/14756366.2023.2193866 |
_version_ | 1785019944262434816 |
---|---|
author | Ahn, Myunghwan Park, Seung Eun Choi, Jiyeon Choi, Jiahn Choi, Doyoung An, Dongju Jeon, Hayoung Oh, Soowhan Lee, Kiho Kim, Jaehoon Jang, Jaebong Kim, Seyun Byun, Youngjoo |
author_facet | Ahn, Myunghwan Park, Seung Eun Choi, Jiyeon Choi, Jiahn Choi, Doyoung An, Dongju Jeon, Hayoung Oh, Soowhan Lee, Kiho Kim, Jaehoon Jang, Jaebong Kim, Seyun Byun, Youngjoo |
author_sort | Ahn, Myunghwan |
collection | PubMed |
description | Inositol polyphosphates (IPs) are a group of inositol metabolites that act as secondary messengers for external signalling cues. They play various physiological roles such as insulin release, telomere length maintenance, cell metabolism, and aging. Inositol hexakisphosphate kinase 2 (IP6K2) is a key enzyme that produces 5-diphosphoinositol 1,2,3,4,6-pentakisphosphate (5-IP7), which influences the early stages of glucose-induced exocytosis. Therefore, regulation of IP6Ks may serve as a promising strategy for treating diseases such as diabetes and obesity. In this study, we designed, synthesised, and evaluated flavonoid-based compounds as new inhibitors of IP6K2. Structure-activity relationship studies identified compound 20s as the most potent IP6K2 inhibitor with an IC(50) value of 0.55 μM, making it 5-fold more potent than quercetin, the reported flavonoid-based IP6K2 inhibitor. Compound 20s showed higher inhibitory potency against IP6K2 than IP6K1 and IP6K3. Compound 20s can be utilised as a hit compound for further structural modifications of IP6K2 inhibitors. |
format | Online Article Text |
id | pubmed-10075506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-100755062023-04-06 Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors Ahn, Myunghwan Park, Seung Eun Choi, Jiyeon Choi, Jiahn Choi, Doyoung An, Dongju Jeon, Hayoung Oh, Soowhan Lee, Kiho Kim, Jaehoon Jang, Jaebong Kim, Seyun Byun, Youngjoo J Enzyme Inhib Med Chem Research Paper Inositol polyphosphates (IPs) are a group of inositol metabolites that act as secondary messengers for external signalling cues. They play various physiological roles such as insulin release, telomere length maintenance, cell metabolism, and aging. Inositol hexakisphosphate kinase 2 (IP6K2) is a key enzyme that produces 5-diphosphoinositol 1,2,3,4,6-pentakisphosphate (5-IP7), which influences the early stages of glucose-induced exocytosis. Therefore, regulation of IP6Ks may serve as a promising strategy for treating diseases such as diabetes and obesity. In this study, we designed, synthesised, and evaluated flavonoid-based compounds as new inhibitors of IP6K2. Structure-activity relationship studies identified compound 20s as the most potent IP6K2 inhibitor with an IC(50) value of 0.55 μM, making it 5-fold more potent than quercetin, the reported flavonoid-based IP6K2 inhibitor. Compound 20s showed higher inhibitory potency against IP6K2 than IP6K1 and IP6K3. Compound 20s can be utilised as a hit compound for further structural modifications of IP6K2 inhibitors. Taylor & Francis 2023-04-04 /pmc/articles/PMC10075506/ /pubmed/37013838 http://dx.doi.org/10.1080/14756366.2023.2193866 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Paper Ahn, Myunghwan Park, Seung Eun Choi, Jiyeon Choi, Jiahn Choi, Doyoung An, Dongju Jeon, Hayoung Oh, Soowhan Lee, Kiho Kim, Jaehoon Jang, Jaebong Kim, Seyun Byun, Youngjoo Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title | Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title_full | Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title_fullStr | Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title_full_unstemmed | Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title_short | Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors |
title_sort | synthesis and biological evaluation of flavonoid-based ip6k2 inhibitors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075506/ https://www.ncbi.nlm.nih.gov/pubmed/37013838 http://dx.doi.org/10.1080/14756366.2023.2193866 |
work_keys_str_mv | AT ahnmyunghwan synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT parkseungeun synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT choijiyeon synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT choijiahn synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT choidoyoung synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT andongju synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT jeonhayoung synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT ohsoowhan synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT leekiho synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT kimjaehoon synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT jangjaebong synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT kimseyun synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors AT byunyoungjoo synthesisandbiologicalevaluationofflavonoidbasedip6k2inhibitors |